← Back to headlines
Merck's Keytruda Shows Survival Benefit in Ovarian Cancer
Merck's cancer drug Keytruda has demonstrated an overall survival benefit in patients with ovarian cancer, according to new findings.
27 Feb, 16:38 — 27 Feb, 16:38
Sources
Showing 1 of 1 sources
Related Stories
Philippine Charity Sweepstakes Office Provides ₱18.2M Aid to Mindoro Healthcare
just now
NGO Provides Health Insurance for Pregnant Women in Enugu
just now
Philippines clears irrigation canals in Bicol to mitigate El Niño impact
just now
Kwara State Government Pledges Improved Immunisation Efforts
just now